Re-Engineering Basic and Clinical Research to Catalyze Translational Nanoscience

具体目标是：-确定未来翻译纳米医学的优先事项并促进研究，借此纳米技术和纳米科学范式将促进药物输送、药物和治疗开发、活体成像、体外诊断、活性植入物和组织修复/再生。-包括来自学术界和工业界的杰出科学家和工程师组成的多学科小组作为演讲者，他们致力于纳米设备和纳米技术的开发，以及来自NIH和霍华德·休斯医学研究所支持的翻译研究项目的有远见的临床研究人员，他们在基因组学、蛋白质组学、多器官系统、分子和与人类常见疾病有关的途径方面具有专长。-激发独特的变革性、新颖性和纳米技术以及综合策略，催化将其应用于临床实践。这包括加快纳米技术的发展，使细胞和亚细胞生理的活体探针成为可能。

The specific objectives are to:-Establish priorities for future translational nanomedicine and stimulate research, whereby nanotechnologies and nanoscience paradigms will facilitate drug delivery, drug and therapeutic development, in vivo imaging, in vitro diagnostics, active implants and tissue repair/regeneration.-Include as speakers a multidisciplinary group of outstanding scientists and engineers from academia and industry working in the materials, biological and physical science disciplines toward the development of nanodevices and nanotechnologies, together with visionary clinicalresearchers from translational research programs supported by NIH and the Howard Hughes Medical Institute who have expertise in genomics, proteomics, multiple organ systems, molecules and pathways implicated in common human diseases.- Stimulate uniquely transformative, novel, and integrative strategies to catalyze the application to clinical practice of. This includes acceleration of the development of nanoscale techniques that enable in vivo probes of cellular and subcellular physiology.